Calcium homeostasis is preserved by using calcium carbonate as a food supplement. Together with dietary phosphate, it creates insoluble complexes that also reduce stomach acidity. It is used to treat the following conditions:
-
It is used for to treat the gastrointestinal distress brought on by these symptoms, along with heartburn, indigestion, sour stomach, and other related symptoms.
-
As a dietary supplement in patients with inadequate calcium intake, osteomalacia, osteoporosis, and rickets.
-
It addition, it is used off-label to treat hypoparathyroidism and hyperphosphatemia in individuals with kidney.
Calcium carbonate Dose in Adults
Note: 1 gm of calcium carbonate = 400 mg of elemental calcium.
Calcium carbonate as an Antacid:
- 1 - 4 tablets to a maximum dose of 8 gms/day orally as calcium carbonate for up to 2 weeks
Use in the treatment of Calcium supplementation (OTC labeling):
Note: For optimal bone health, 1 - 1.2 gms of elemental calcium intake is recommended in adults. Ingestion of high doses of calcium does not improve bone strength.
- 500 mg to 4 gms/day orally as calcium carbonate in 1 to 3 divided doses.
Off label use in the treatment of Hyperphosphatemia in chronic kidney disease:
-
No more than 2 gms of elemental calcium should be consumed daily from all sources. (This is the same as four 1250 gm calcium carbonate tablets)
Off label use in the treatment of Hypoparathyroidism:
- 500 mg to 1 gm elemental calcium taken orally 2 - 3 times a day.
Calcium carbonate Dose in Childrens
Adequate intake (AI):
- 1 - 6 months:
- 200 mg/day of elemental calcium orally.
- 7 - 12 months:
- 260 mg/day of elemental calcium orally.
Recommended daily allowance (RDA):
- 1 - 3 years:
- 700 mg/day of elemental calcium orally.
- 4 - 8 years:
- 1,000 mg/day of elemental calcium orally.
- 9 - 18 years:
- 1,300 mg/day of elemental calcium orally.
Use as an Antacid (chronic therapy for GERD is not recommended):
- Children 2 - 5 years, weighing more than 10.9 kg:
- 375–400 mg calcium carbonate taken orally for a period of up to two weeks, with a daily dose cap of 1,500 mg.
- Children 6 - 11 years:
- 750 - 800 mg orally for up to 2 weeks to a maximum daily dose of 3,000 mg/day of calcium carbonate
- Children older than 12 years and Adolescents:
- 500 - 3,000 mg orally for up to 2 weeks to a maximum daily dose of 7,500 mg/day of calcium carbonate
Use in the treatment of Calcium dietary supplementation:
- Children 2 - 4 years:
- 750 mg of calcium carbonate orally twice a day
- Children older than 4 years and Adolescents:
- 750 mg of calcium carbonate orally thrice a day
Use in the treatment of Hypocalcemia:
- Infants and Children:
- 45 - 65 mg/kg/day of elemental calcium orally in 4 divided doses.
Use in the treatment of Hyperphosphatemia in chronic kidney disease:
- Infants, Children, and Adults:
- The total calcium intake should not exceed 2 gms per day.
- 1,500 mg/day of elemental calcium should not be obtained through phosphate binders.
Use for treating Rickets due to vitamin D deficiency:
- Infants and Children:
- 30 - 75 mg/kg/day of elemental calcium orally in 3 divided doses
- Initiate treatment at a higher dose and titrate downwards.
Pregnancy Risk Factor B
- Calcium crosses the placental boundary and is necessary for fetal development.
- During pregnancy, there is an increase in calcium excretion from the urine and intestinal absorption.
- Calcium requirements for pregnant and unpregnant women are identical.
- It can safely be used during pregnancy as an anti-inflammatory agent at the recommended dosage.
Calcium Carbonate use during breastfeeding:
- Breast milk contains calcium, which is necessary for milk production.
- The calcium requirements of lactating and nonlactating women are identical.
Calcium carbonate Dose in renal impairment:
- Patients with CrCl of less than 25 mL/minute require adjustment in the dose based on the serum calcium levels.
Calcium carbonate Dose in Liver Disease:
- Dose adjustement in patients with liver disease has not been recommended by the manufacturer.
Common Side Effects of Calcium Carbonate Include:
- Central nervous system:
- Laxative effect
- Headache
- Endocrine & metabolic:
- Hypophosphatemia
- Hypercalcemia
- Milk-alkali syndrome (manifested by headache, nausea, irritability, and weakness or alkalosis, hypercalcemia, and renal impairment)
- Gastrointestinal:
- Anorexia
- Vomiting
- Constipation
- Hyperacidity (acid rebound)
- Flatulence
- Nausea
- Xerostomia
- Abdominal pain
Contraindication to Calcium Carbonate include:
- Allergy reactions to calcium carbonate and any component of the formulation
Warnings and Precautions
-
- Gastrointestinal effects:
- It can cause flatulence, constipation, and bloating.
- Gastrointestinal effects:
- Hypercalcemia:
- Acute and progressive hypercalcemia, which can result in seizures and cardiac arrhythmias, may be experienced by patients who consume high doses of calcium carbonate over an extended period of time.
- A chronic elevation in calcium levels can lead to generalized vascular or soft-tissuecalcification, which may eventually lead to nephrolithiasis.
- Patients with chronic renal disease who have hypercalcemia have a higher mortality rate.
- Concomitant medications like thiazide diuretics may increase the risk of hypercalcemia.
- Achlorhydria:
- Patients suffering from achlorhydria have lower calcium absorption.
- You should administer it with food, or use alternative agents.
- Chronic kidney disease
- Patients suffering from CKD should be given other phosphate binders such as sevelamer and lanthanum, especially if their serum calcium levels are high or normal.
- non-calcium based phosphate binders are thought to reduce cardiovascular mortality in patients with CKD compared to calcium acetate and calcium carbonate.
- Hypoparathyroidism:
- High dosages of vitamin D may cause hypercalcemia and hypercalciuria in hypoparathyroid individuals.
- Kidney stones
- Calcium supplements should be used with caution for patients with kidney stones.
- Insufficiency of the renal system:
- Calcium supplements should be used with caution by patients with renal impairment.
Calcium carbonate: Drug Interaction
Amphetamines |
The excretion of amphetamines may be decreased by antacids. |
Antipsychotic Agents (Phenothiazines) |
Antacids may reduce how well antipsychotic agents are absorbed (Phenothiazines). |
Bromperidol |
Antacids might make it harder for bromperidol to be absorbed. |
Calcium Channel Blockers |
The therapeutic benefit of calcium channel blockers may be reduced by calcium salts. |
Captopril |
Antacids may lower the level of captopril in the blood. |
Cardiac Glycosides |
Cardiac Glycosides' ability to induce arrhythmias may be increased by calcium salts. |
Cefpodoxime |
Cefpodoxime serum levels may be lowered by antacids. |
Cysteamine (Systemic) |
Antacids may reduce Cysteamine's therapeutic impact (Systemic). |
Dexmethylphenidate |
Dexmethylphenidate's absorption may be accelerated by antacids. Antacids specifically have the potential to disrupt the usual medication release from the extended-release capsules (Focalin XR brand), which may increase early absorption and reduce delayed absorption. |
Diacerein |
Antacids might make it harder for diacerein to be absorbed. |
DOBUTamine |
Calcium salts may lessen DOBUTamine's therapeutic effects. |
Methylphenidate |
Methylphenidate's absorption could be accelerated by antacids. Antacids, specifically, may prevent the extended-release capsules (Ritalin LA brand) from releasing the medicine normally, which may lead to increased early absorption and decreased delayed absorption. |
QuiNIDine |
QuiNIDine excretion might be decreased by antacids. |
Rosuvastatin |
Rosuvastatin's serum levels may drop when using antacids. |
Thiazide and Thiazide-Like Diuretics |
Calcium Salts' excretion might be reduced. Metabolic alkalosis can also be brought on by continued concurrent usage. |
Vitamin D Analogs |
The harmful or poisonous effect of vitamin D analogues may be increased by calcium salts. |
Risk Factor D (Consider therapy modification) |
|
Acalabrutinib |
The serum concentration of acalabrutinib may be lowered by antacids. Management: To reduce the possibility of a major interaction, administer acalabrutinib at least two hours apart from the administration of any antacids. |
Allopurinol |
Antacids could make it harder for allopurinol to be absorbed. |
Alpha-Lipoic Acid |
Alpha-Lipoic Acid may not be absorbed as well when exposed to calcium salts. The absorption of calcium salts may be decreased by alpha-lipoic acid. |
Atazanavir |
Antacids might make it harder for atazanavir to be absorbed. |
Bictegravir |
Calcium salts may lower the level of bictegravir in the blood. Treatment: Under fed settings, bictegravir, emtricitabine, and tenofovir alafenamide can be provided with calcium salts; however, under fasting conditions, coadministration with or two hours after a calcium salt is not advised. |
Bisacodyl |
Antacids may lessen Bisacodyl's medicinal effects. The delayed-release bisacodyl pills could release the medication before they reach the big intestine if you take antacids. There may be gastric discomfort and/or cramping. |
Bismuth Subcitrate |
The therapeutic benefit of bismuth subcitrate may be reduced by antacids. Management: Tripotassium bismuth dicitrate (bismuth subcitrate) should not be taken within 30 minutes of taking antacids. |
Bisphosphonate Derivatives |
Products containing polyvalent cations may lower the level of bisphosphonate derivatives in the serum. The following oral drugs should not be used within the following time frames: 2 hours before or after tiludronate/clodronate/etidronate; 60 minutes after oral ibandronate; or 30 minutes after alendronate/risedronate. Exceptions: Zoledronic Acid; Pamidronate |
Bosutinib |
.Bosutinib's serum levels may drop when using antacids. Treatment: Give antacids at least two hours before or after taking bosutinib |
Calcium Polystyrene Sulfonate |
The hazardous or harmful effects of calcium polystyrene sulfonate may be increased by antacids. Combining these two drugs may result in metabolic alkalosis and/or reduce the efficiency of the cation exchange resin. Management: To lessen this interaction, consider splitting doses by at least two hours, injecting the exchange resin, or avoiding antacids altogether. Keep an eye out for metabolic alkalosis and diminished CPS effects. Steer clear of magnesium hydroxide. |
Cefditoren |
Cefditoren's serum concentration may drop when taking antacids. Management: It is not advised to use antacids and cefditoren together. Take into account alternate means of controlling acid reflux, such as dietary changes or alternative antibacterial medication. If using antacid treatment is unavoidable, space out doses by several hours. |
Cefuroxime |
Antacids may lower the level of cefuroxime in the blood. Treatment: Give cefuroxime axetil at least an hour before or two hours after antacids with a short half-life. |
Chloroquine |
Chloroquine serum levels may be reduced by antacids. To reduce any potential adverse effects of antacids on chloroquine bioavailability, administration of antacids and chloroquine should be separated by at least 4 hours. |
Corticosteroids (Oral) |
Corticosteroids' bioavailability may be lowered by antacids (Oral). Management: Take into account dividing dosages by two hours or more. If used along with medications that suppress gastric acid, budesonide enteric coated tablets may dissolve too soon, with uncertain implications on the therapeutic effects of budesonide. |
Dabigatran Etexilate |
The serum concentration of dabigatran etexilate may be lowered by antacids. Management: The Canadian product labelling for dabigatran etexilate advises against using antacids concurrently for 24 hours following surgery. In other cases, give dabigatran etexilate two hours before taking antacids. watch the way your body responds to dabigatran treatment. |
Dasatinib |
Antacids may lower the dasatinib serum levels. Management: Dasatinib and antacids shouldn't be administered at the same time. Give antacids two hours before or after taking dasatinib. |
Deferiprone |
Products containing polyvalent cations may lower the level of deferiprone in the serum. Treatment: Give deferiprone at least four hours apart from oral drugs or dietary supplements containing polyvalent cations. |
Delavirdine |
Delavirdine's serum levels may drop when using antacids. Treatment: Give delavirdine and antacid dosages at least an hour apart. With this combination, keep an eye out for diminished delavirdine therapeutic effects. |
Dolutegravir |
Dolutegravir's serum levels may be lowered by calcium salts. Treatment: Dolutegravir should be administered at least two hours before or six hours after oral calcium. Dolutegravir/rilpivirine should be administered at least 4 hours before or 6 hours after taking oral calcium salts. Oral calcium and dolutegravir can also be consumed with meals. |
Eltrombopag |
Products containing polyvalent cations may lower the serum concentration of eltrombopag. Treatment: Give eltrombopag at least two hours before or four hours after taking any oral medication containing polyvalent cations. |
Elvitegravir |
Elvitegravir's serum concentration may drop when using antacids. To reduce the possibility of an interaction, it is best to administer antacids at least two hours apart from products containing elvitegravir. |
Erlotinib |
Antacids may lower the level of erlotinib in the blood. Management: To reduce the possibility of a major interaction, give erlotinib many hours apart from any antacid. |
Estramustine |
Calcium salts might make it harder for estramustine to be absorbed. |
Fosinopril |
Antacids may lower the level of fosinopril in the blood. Management: Separating the doses of antacids and fosinopril by two hours is advised on the manufacturer's labelling for the drug in the US and Canada. |
Gefitinib |
Antacids may lower the level of gefitinib in the blood. Carefully evaluate the clinical response to gefitinib and administer gefitinib at least 6 hours before or after taking an antacid. |
Hyoscyamine |
Hyoscyamine levels in the serum may drop when using antacids. When taking these medications together, administer instant release hyoscyamine before meals and antacids afterward. |
Iron Salts |
Antacids might make it harder for iron salts to be absorbed. Ferric Carboxymaltose, Ferric Citrate, Ferric Gluconate, Ferric Hydroxide Polymaltose Complex, Ferumoxytol, Iron Dextran Complex, Iron Isomaltoside, and Iron Sucrose are exceptions |
Itraconazole |
The serum levels of itraconazole may rise when using antacids. Itraconazole's serum levels may drop when using antacids. Treatment: Give itraconazole under the brand name Sporanox at least two hours before or two hours after taking any antacids. Antacids may enhance the exposure to itraconazole of the Tolsura brand; you should think about lowering the dose. |
Ketoconazole (Systemic) |
The serum concentration of ketoconazole may be lowered by antacids (Systemic). Treatment: Give oral ketoconazole at least two hours before using any antacid medication. Patients should be cautiously watched for indications of a poor clinical response to ketoconazole. |
Lanthanum |
Antacids may lessen lanthanum's medicinal effects. |
Ledipasvir |
Ledipasvir's serum levels may be lowered by antacids. Management: Give ledipasvir 4 hours apart from antacids while taking them. |
Mesalamine |
Antacids may reduce Mesalamine's therapeutic impact. Specific sustained-release mesalamine formulations may prematurely release mesalamine due to elevations in stomach pH brought on by antacids. Avoid taking antacids at the same time as sustained-release mesalamine products. Using lower antacid doses or separating the delivery of antacid and mesalamine may be sufficient methods of preventing this interaction. |
Methenamine |
Antacids may reduce Methenamine's medicinal impact. |
Multivitamins/Fluoride (with ADE) |
Calcium salts' serum concentration might rise. Fluoride and multivitamin serum concentrations may be lowered by calcium salts (with ADE). More specifically, calcium salts might make it harder for people to absorb fluoride. Treatment: Refrain from taking dairy products, vitamins, or dietary supplements containing calcium salts an hour before or an hour after receiving fluoride. |
Multivitamins/Minerals (with ADEK, Folate, Iron) |
The serum content of multivitamins and minerals may drop when taking antacids (with ADEK, Folate, Iron). Antacids specifically may reduce the absorption of iron given orally. Treatment: To reduce effects on the iron preparation's therapeutic efficacy, separate oral iron-containing multivitamin preparations from antacids by as much time as possible. |
Mycophenolate |
Antacids could make it harder for mycophenolate to be absorbed. Treatment: Give mycophenolate and antacid dosages at least two hours apart. If mycophenolate and antacids are taken at the same time, watch for any diminished effects. |
Neratinib |
Antacids may lower the level of Neratinib in the serum. Antacids specifically may reduce the absorption of neratinib. Management: Give neratinib at least three hours after taking an antacid to keep the two medications apart. |
Nilotinib |
Antacids may lower the level of nilotinib in the blood. Management: To reduce the possibility of a significant interaction, administer nilotinib and any antacids at least 2 hours apart whenever possible. |
PAZOPanib |
Antacids may lower the level of PAZOPanib in the serum. Management: Whenever possible, refrain from taking antacids with pazopanib. Several hours should pass between doses if antacid treatment is thought to be essential. There has not been research done on the effects of dosage separation. |
PenicillAMINE |
Products containing polyvalent cations may lower the level of penicillAMINE in the serum. Treatment: Give oral medications containing polyvalent cations and penicillamine at least an hour apart. |
Phosphate Supplements |
The absorption of phosphate supplements may be reduced by antacids. Management: Only oral phosphate delivery is covered by this. By keeping oral phosphate supplementation and antacid delivery apart for as long as feasible, the interaction may be reduced. Exceptions: Pentahydrate of sodium glycerophosphate. |
Phosphate Supplements |
Phosphate supplements' absorption may be reduced by calcium salts. Management: This only pertains to the oral administration of calcium and phosphate. The importance of the interaction may be reduced by giving oral phosphate supplements as widely apart as possible from giving an oral calcium salt. Exceptions: Pentahydrate of sodium glycerophosphate. |
Potassium Phosphate |
Potassium phosphate levels in the serum may drop when taking antacids. Management: To reduce the chance of a significant interaction, think about giving antacids and oral potassium phosphate at least two hours apart. |
Quinolones |
Quinolones may be less absorbed when taken with antacids. To lessen the effects of this combination, avoid giving quinolones and antacids at the same time. Optimal dosage separation recommendations differ depending on the particular quinolone. Other than LevoFLOXacin (Oral Inhalation). |
Quinolones |
Quinolones may be less readily absorbed if you take calcium salts only when both drugs are administered orally. LevoFLOXacin (oral inhalation) and moxifloxacin are exceptions (Systemic). |
Raltegravir |
Calcium carbonate may lower the level of raltegravir in the blood. |
Rilpivirine |
Rilpivirine's serum concentration may drop when using antacids. Treatment: Give antacids at least 2 hours prior to or 4 hours following the administration of rilpivirine. Give antacids at least 6 hours before or 4 hours after taking a product containing rilpivirine and dolutegravir. |
Riociguat |
Riociguat's serum levels may drop when taking antacids. Management: To reduce the possibility of an interaction, provide antacids and riociguat at least an hour apart. |
Sodium Polystyrene Sulfonate |
The hazardous or harmful effects of sodium polystyrene sulfonate may be increased by antacids. Combining these two medications may cause metabolic alkalosis and/or decrease the effectiveness of the exchange resin. Management: To reduce this interaction, think about a) separating doses by at least two hours, b) administering the exchange resin intravenously, or c) finding alternatives to antacids. Keep an eye out for metabolic alkalosis and diminished SPS effects. Steer clear of magnesium hydroxide. |
Sotalol |
Antacids may lower the level of sotalol in the blood. Management: Steer clear of giving sotalol and antacids at the same time. 2 hours after taking sotalol, provide antacids. |
Strontium Ranelate |
Strontium Ranelate serum levels may be reduced by calcium salts. To reduce this interaction, strontium ranelate and oral calcium salts should be administered at least two hours apart. |
Sulpiride |
Antacids may lower the level of Sulpiride in the blood. Management: To reduce the effect of antacids on sulpiride absorption, administer antacids and sulpiride at least two hours apart. |
Tetracyclines |
Tetracyclines may not be absorbed as well when taken with antacids. When possible, administer antacids and oral tetracycline derivatives at different times to reduce the severity of this potential interaction. Eravacycline is an exception. |
Thyroid Products |
The therapeutic value of thyroid products may be reduced by calcium salts. Treatment: Give the thyroid medication and the oral calcium supplement at least 4 hours apart. |
Trientine |
Products containing polyvalent cations may lower the level of trientine in the serum. Management: Steer clear of combining the use of oral medications containing polyvalent cations with trientine. If you need to take oral iron supplements, space out the administration by two hours. Separate administration of other oral polyvalent cations by one hour if necessary. |
Velpatasvir |
Antacids may lower Velpatasvir's serum levels. Treatment: Velpatasvir and antacids should be taken at least 4 hours apart. |
Risk Factor X (Avoid combination) |
|
Baloxavir Marboxil |
Products containing polyvalent cations may lower the level of baloxavir marboxil in the serum. |
Calcium Acetate |
Calcium Salts may intensify Calcium Acetate's harmful or poisonous effects. |
Monitor:
- Plasma calcium levels (especially if used for the treatment of hypocalcemia and hypoparathyroidism).
- Phosphate
- Magnesium
- Renal function
- 24-hour urinary calcium and creatinine,
- Renal imaging every five years in asymptomatic patients with a history of nephrolithiasis or nephrocalcinosis
- CNS imaging for basal ganglia calcification
- Ophthalmologic exam
- Bone mineral density
- Hyperphosphatemia
CKD stage G3a to G3b:
- Serum calcium and phosphate:
- Monitor every 6 - 12 months
- Parathyroid hormone
CKD stage G4:
- Serum Calcium and phosphate:
- Monitor every 3 - 6 months
- Parathyroid hormone:
- Monitor every 6 - 12 months
CKD stage G5 and G5D:
- Serum calcium and phosphate:
- Monitor every 1 - 3 months
- Parathyroid hormone:
- Monitor every 3 - 6 months
How to administer Calcium Carbonate?
- It is administered orally with food.
- If you need to take more than 600 mg of elemental calcium per day, you should take it in divided doses.
Mode of action of Calcium Carbonate:
- Calcium carbonate can be used as a dietary supplement to maintain osteoporosis's negative calcium balance and prevent or reduce bone loss.
- It's also important for the optimal function of nerve, muscle and cardiac functions.
- In patients with chronic renal illness, it can also be used to treat hyperphosphatemia by interacting with phosphate to create insoluble molecules.
- Additionally, it can be used as an anti-antacid to reduce gastric acidity, block pepsin's proteolytic activity, and raise lower esophageal tone.
It is only minimally absorbedIf high doses of vitamin D are not given, it is unlikely that the patient will be able to absorb them.
Vitamin D levels and patient age are also important factors. Pregnancy doubles the rate of absorption. Calcium isabsorbedIn an ionized and acidic form.AbsorptionPatients with achlorhydria and renal osteodystrophy, Steatorrhea, and Uremia have a decreased risk It isdistributedIt is found mainly in the bones and teeth, and is 40%protein-boundIt is mainly due to albumin. It is excreted primarily from the feces.
Calcium Carbonate international brand names:
- Antacid Calcium Extra Strength
- Antacid Calcium
- Antacid Extra Strength
- Antacid
- Cal-Carb Forte
- Cal-Gest Antacid
- Cal-Mint
- Calci-Chew
- Calcium - 600
- Calcium Antacid Extra Strength
- Calcium Antacid Ultra Max St
- Calcium
- Antacid
- Calcium High Potency
- Caltrate 600
- Florical
- Maalox Childrens
- Maalox
- Oysco 500
- Titralac
- Tums Chewy Bites
- Tums Chewy Delights
- Tums E-X 750
- Tums Extra Strength 750
- Tums Freshers
- Tums Kids
- Tums Lasting Effects
- Tums Smoothies
- Tums Ultra 1000
- Tums
- Acical
- Additiva Calcium
- Andrews TUMS Antacid
- Apo-Cal
- Bica
- Bo-Ne-Ca
- Bonacal
- Boncal
- Bonfit
- Cal-Sup
- Calbo
- Calcanate
- Calcefor
- Calci Aid
- Calcichew
- Calcifar
- Calcigamma
- Calcigran Sine
- Calcilos
- Calcimate
- Calcimate Forte
- Calcit
- Calcium
- Calcium Carbonate
- Calcium Dago
- Calcium Genericon
- Calcium Klopfer
- Calcium-Carbonat Salmon
- Pharma
- Calcium-Phosphatbinder Bichsel
- Calcium-Sandoz Forte
- Calciumcarbonat
- Fresenius
- Calciumcarbonat-Dial
- Calcuren
- Calnat
- Calos
- Calperos
- Calsuba
- Calsum
- Calsum Forte
- Caltab
- Caltess
- Caltrate 600
- Caltrón
- Cantacid
- Capool
- CC-Nefro 500
- Chooz Antacid Gum 500
- Cimascal
- Cipcal
- Dreisacarb
- Edee
- Fixateur phospho-calcique
- Bichsel
- Fixical
- FructiCal
- Gastrocid
- Iroviton Calcium
- Isofem
- Jasocal
- Kalcidon
- Kalcij-karbonat
- Kalcijev karbonat
- Kalcitena
- Kalzonorm
- Maxi-calc
- Maxi-Kalz
- Mubonet
- N-Zarevet
- Natecal
- Noacid
- Orocal
- Oscal
- Osteocal 500
- Osteomin
- Pharcal
- Pluscal
- Rowarolan
- Rowarolan Powder
- Seacal
- Tetesept
- Calcium
- Titralac
- Tums
- Tums EX Sugar Free
- Tums Smoothies EX Peppermint
- Tums Ultra Spearmint
- Vicalvit
- Vitacalcin
- Weifa-
- Kalsium
Calcium carbonate Brands in Pakistan:
Calcium Carbonate [Inf 0.48 gm] |
|
MACRIN RS | SEARLE PAKISTAN (PVT.) LTD. |
Calcium Carbonate [Tabs 50 mg] |
|
CALCIDIN | PHARMEDIC (PVT) LTD. |
Calcium Carbonate [Tabs 1250 mg] |
|
CALCIBONE | GEOFMAN PHARMACEUTICALS |
CALTAB CHEWABLE | WERRICK PHARMACEUTICALS |
OYSTERCAL-500 | PHARMAKO PAKISTAN |
QALSAN MIXED FRUIT | NOVARTIS PHARMA (PAK) LTD |